KP-294

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameKP-294
Drug Alias NameKP-294
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel agonists
TargetsPotassium channel
Therapy Area/IndicationsHypertensionAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaken Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertensionAsthma

Other Information

ATC CodeN/A
Related LinksN/A